Infuse Bone Graft
Device Bone Matrix/Graft
PDI 00681490843782
General payments
$605,769
Research payments
$5,680,442
Through program year 2025, $605,769 in general payments and $5,680,442 in research payments were reported against Infuse Bone Graft (Bone Matrix/Graft).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $164,515 | 97 |
| 2025 | Research | $1,730,721 | 399 |
| 2024 | General | $242,910 | 222 |
| 2024 | Research | $1,721,237 | 373 |
| 2023 | General | $46,410 | 45 |
| 2023 | Research | $1,119,049 | 281 |
| 2022 | General | $151,933 | 195 |
| 2022 | Research | $1,109,434 | 274 |
Breakdown
The top 5 of 51 recipients; each share is of general payments naming this product in 2025.
The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 24 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
559 general · 1,327 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.